A comprehensive meta-analysis demonstrates that AS-IV significantly improves LVEF, reduces left ventricular end-diastolic pressure, downregulates myocardial creatine kinase and troponin expression, optimizes ST segment depression, and minimizes the MI area (Zheng et al., 2018)
The 12-month commitment may feel long, but its well-rated group-based approach helps many members succeed
You can but you do not have to
Not every patient needs the full longevity stack
Who should not use GLP BodyGuard
Given that GLP-1 agonists can cause gastroparesis, there is increased concern for ileus when the patient is taking an antipsychotic medication with a high ACB, such as Clozapine, Olanzapine, Quetiapinethe same medications for which we are wanting to manage metabolic side effect consequences